Sumitomo Dainippon Pharma Annual Report 2017
78/102

Notes to Consolidated Financial StatementsSumitomo Dainippon Pharma Co., Ltd. and Consolidated SubsidiariesYears Ended March 31, 2017 and 2016Financial SectionMillions of yen¥ —————¥ ——————20926¥ 235¥ —DifferenceFair values¥ 71,4092,670109,02916,81972,980¥ 272,90710650,4131,49440,0008,81820,2098,026¥ 129,066¥ (31)Book values¥ 71,4092,670109,02916,81972,980¥ 272,90710650,4131,49440,0008,81820,0008,000¥ 128,831¥ (31)2017(1) Cash and time deposits(2) Trade notes(3) Trade accounts(4) Due from parent company, unconsolidated subsidiaries and afliates(5) Marketable securities and investment securities Total assets(1) Trade notes(2) Trade accounts(3) Due to parent company, unconsolidated subsidiaries and afliates(4) Short-term loans payable(5) Income taxes payable(6) Bonds payable (*1)(7) Long-term loans payable (*2) Total liabilities Derivative transactions(*1) Bonds payable include the amount of current portion of long-term bonds payable.(*2) Long-term loans payable are the amount of current portion of long-term loans payable.purpose of hedging risks of uctuations in exchange rates of receivables and payables denominated in foreign currencies. With respect to foreign exchange forward contracts, the Finance & Accounting Division formulates an implementation plan for hedging foreign currency risks every six months pursuant to the Company’s policies in respect of management of foreign currency risks. Upon reporting to the Representative Director, President and Chief Executive Ofcer, transactions are then executed and the related entries posted. The results of derivative transactions are also reported to the Representative Director, President and Chief Executive Ofcer. Certain consolidated subsidiaries also set forth internal policies pertaining to forward exchange contracts and engage in transactions in accordance therewith. See “Derivative Financial Instruments” as stated in the above “Summary of Signicant Accounting Policies” for information on hedging instruments, hedged items, hedging policy, and the method by which the effectiveness of hedging is evaluated, as they relate to hedge accounting.3) Supplemental information on fair values of nancial instrumentsThe fair values of nancial instruments are based on market prices. Reasonably estimated values are used as fair values for nancial instruments with no available fair market prices. Various assumption used in the calculation of the reasonably estimated values may affect calculation of values.Book values and fair values of the nancial instruments on the consolidated balance sheet as of March 31, 2017 and 2016 were as follows:Sumitomo Dainippon Pharma Co., Ltd. Annual Report 201777

元のページ  ../index.html#78

このブックを見る